Robert A Anders Selected Research

Thrombocytopenia (Thrombopenia)

12/2021

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A Anders Research Topics

Disease

72	Neoplasms (Cancer) 12/2021 - 01/2006
14	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2010
12	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2012
12	Carcinogenesis 01/2021 - 03/2003
11	Melanoma (Melanoma, Malignant) 11/2021 - 03/2012
9	Adenocarcinoma 01/2021 - 04/2011
8	Inflammation (Inflammations) 01/2021 - 03/2004
8	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020 - 04/2009
7	Fibrosis (Cirrhosis) 01/2022 - 03/2003
5	Cholangiocarcinoma 01/2022 - 09/2012
5	Liver Diseases (Liver Disease) 11/2021 - 09/2011
4	Neoplasm Metastasis (Metastasis) 01/2019 - 04/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 06/2012
4	Liver Neoplasms (Liver Cancer) 01/2016 - 09/2012
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 03/2004
3	Infections 01/2018 - 01/2014
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 06/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 01/2013
3	Hepatomegaly 06/2012 - 07/2005
2	End Stage Liver Disease 01/2022 - 01/2018
2	Weight Loss (Weight Reduction) 01/2022 - 01/2022
2	Myocarditis (Carditis) 10/2021 - 11/2016
2	Weight Gain 09/2020 - 10/2018
2	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 05/2012
2	Microsatellite Instability 12/2019 - 10/2019
2	Merkel Cell Carcinoma 10/2018 - 07/2013
2	Carcinoma (Carcinomatosis) 09/2017 - 06/2015
2	Turcot syndrome 01/2017 - 06/2015
2	Cholestasis 12/2016 - 05/2014
2	Circulating Neoplastic Cells 12/2016 - 10/2016
2	Hypoxia (Hypoxemia) 10/2015 - 04/2009
2	Body Weight (Weight, Body) 06/2015 - 06/2012
1	Hemoglobin SC Disease (Disease, Hemoglobin SC) 01/2022
1	Autoimmune Hepatitis 01/2022
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022
1	Neoplasm Micrometastasis 01/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2021
1	Thrombocytopenia (Thrombopenia) 12/2021
1	Exanthema (Rash) 12/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2008
14	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2013
14	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
8	LigandsIBA 12/2021 - 03/2004
7	CytokinesIBA 01/2018 - 03/2005
6	NivolumabIBA 01/2022 - 01/2013
6	B7-H1 AntigenIBA 12/2021 - 01/2017
6	AntigensIBA 01/2021 - 03/2005
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2015
6	VaccinesIBA 01/2021 - 01/2015
6	ParaffinIBA 01/2020 - 01/2013
6	Transcription Factors (Transcription Factor)IBA 07/2017 - 04/2009
6	AntibodiesIBA 01/2017 - 04/2011
5	Formaldehyde (Formol)FDA Link 01/2020 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2009
4	pembrolizumabIBA 01/2020 - 06/2015
4	EnzymesIBA 01/2019 - 04/2009
3	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 03/2012
3	IpilimumabIBA 11/2021 - 11/2016
3	Tumor Biomarkers (Tumor Markers)IBA 12/2019 - 10/2016
3	Annexin A2 (Annexin II)IBA 01/2019 - 04/2011
3	Pharmaceutical PreparationsIBA 01/2018 - 02/2015
3	InterferonsIBA 07/2017 - 03/2012
3	Phosphotransferases (Kinase)IBA 12/2015 - 01/2006
3	Lymphotoxin beta ReceptorIBA 05/2007 - 03/2004
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2021 - 07/2017
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 01/2020
2	Nonmuscle Myosin Type IIBIBA 01/2019 - 02/2015
2	Nonmuscle Myosin Type IIAIBA 01/2019 - 02/2015
2	Protein Isoforms (Isoforms)IBA 01/2018 - 08/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2014
2	Complement System Proteins (Complement)IBA 01/2018 - 05/2009
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2017 - 01/2014
2	Messenger RNA (mRNA)IBA 11/2016 - 07/2011
2	CTLA-4 AntigenIBA 01/2016 - 01/2015
2	CurcuminIBA 12/2015 - 09/2011
2	PolyphenolsIBA 12/2015 - 09/2011
2	Semaphorins (Semaphorin)IBA 08/2015 - 03/2003
2	Biological ProductsIBA 03/2013 - 05/2007
2	Neurofibromin 2 (Merlin)IBA 06/2012 - 07/2010
2	Lymphotoxin-alpha (Lymphotoxin)IBA 07/2005 - 06/2005
2	Glycoproteins (Glycoprotein)IBA 07/2005 - 06/2005
2	Caveolin 1IBA 03/2004 - 03/2003
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021
1	atezolizumabIBA 12/2021
1	cobimetinibIBA 12/2021
1	Inhibins (Inhibin)IBA 11/2021
1	Histone Deacetylase InhibitorsIBA 11/2021

Therapy/Procedure

34	Therapeutics 01/2022 - 08/2010
15	Immunotherapy 01/2022 - 01/2013
9	Liver Transplantation 01/2022 - 05/2009
4	Radiotherapy 10/2018 - 01/2016
3	Microspheres (Microsphere) 01/2022 - 10/2018
3	Drug Therapy (Chemotherapy) 01/2020 - 11/2017
3	Castration 01/2018 - 06/2012
3	Transplantation 01/2018 - 03/2007
2	Aftercare (After-Treatment) 11/2016 - 01/2015
1	Molecular Targeted Therapy 01/2022